Offer - Urjas Oil for just ₹ 1
Invokana 300 Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes Type 2. Invokana 300 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Invokana 300 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Invokana 300 Tablet include Excessive Thirst. Some other side effects of Invokana 300 Tablet have been listed ahead. Such side effects of Invokana 300 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Invokana 300 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Invokana 300 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Invokana 300 Tablet related warnings section.
Individuals suffering from medical conditions like Kidney Disease must refrain from the use of Invokana 300 Tablet since this can cause severe adverse effects. The section on Invokana 300 Tablet contraindications lists all such conditions.
Additionally, Invokana 300 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Invokana 300 Tablet is safe while driving, and is is addictive in nature.
Invokana 300 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Invokana 300 Tablet safe for pregnant women?
Invokana can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Invokana 300 Tablet safe during breastfeeding?
Taking Invokana may lead to serious side effects if you are breastfeeding. Invokana should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Invokana 300 Tablet on the Kidneys?
Invokana has very mild side effects on the kidneys.
What is the effect of Invokana 300 Tablet on the Liver?
Invokana is rarely harmful for the liver.
What is the effect of Invokana 300 Tablet on the Heart?
You can take Invokana without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Invokana 300 Tablet unless your doctor advises you to do so -
Is this Invokana 300 Tablet habit forming or addictive?
No, you will not get addicted to Invokana 300 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Invokana 300 Tablet since it will not make you feel sleepy.
Is it safe?
Invokana 300 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Invokana 300 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Invokana 300 Tablet
Eating certain foods may increase the time it takes Invokana 300 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Invokana 300 Tablet
Consuming Invokana 300 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Invokana(canagliflozin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 270-271